Kuang-Chao Cheng1,2, Yu-Hsin Lin1,2, Dao-Sian Wu1,2

  • 1Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Frontiers in immunology
|November 24, 2025
PubMed
概括

由于治疗不有效,卵巢癌 (OC) 的生存率仍然很差. 与瘤相关的巨细胞 (TAMs) 和中性粒细胞 (TANs) 驱动免疫抑制和疾病进展,表明新的治疗点.